Alzheimer’s Advocates Are Demanding Access to FDA-Approved Alzheimer’s Treatments

Recognizing AIM’s April Advocate of the Month: Belinda Jennings

Alzheimer’s Advocates Turn House Budget Hearings Purple, Building Bipartisan Momentum for Access to FDA-Approved Alzheimer’s Treatments